©2024 Stanford Medicine
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting
I'm InterestedTrial ID: NCT02848274
Purpose
The purpose of the study is to develop a prognostic index model for the rare disease of
mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical
data at various institutions. The investigators hope this will enable the identification of
low- and high-risk groups for survival in order to improve patient care and outcome.
Official Title
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Stanford Investigator(s)
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Eligibility
Inclusion Criteria
- Diagnosis of advanced stage MF or SS (Stages IIB - IVB) within 6 months of
presentation to the participating center
- Patients that are expected to have care administered at the participating center or
jointly with referring physician(s) where follow-up data would be available
Exclusion Criteria
- Patients diagnosed with early stage MF/SS (Stages IA-IIA) before progressing to
advanced stage
- Patients diagnosed with advanced MF/SS more than 6 months prior to initial
presentation to the participating center
- Exclude one-time consultation type of new patients.
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tatiana Neal
650-709-7838